Who invested in Enrich Therapeutics?
Enrich Therapeutics's investors include National Institutes of Health, Connecticut Innovations and National Institute of Allergy and Infectious Diseases.

Funding summaryUpdated 26 Oct 2026
$1.7Mraised across 1 round since 2020, from 1 source
Enrich Therapeutics's investors include National Institutes of Health, Connecticut Innovations and National Institute of Allergy and Infectious Diseases.
Enrich Therapeutics has raised $1.7M across 1 round since 2020.
Enrich Therapeutics's most recent round was a Grant of $1.7M in Aug 2020.
Its most recent round, $1.7M in Aug 2020, is also its largest on record.
Enrich Therapeutics's first round on record, in Aug 2020, was backed by National Institutes of Health, Connecticut Innovations and National Institute of Allergy and Infectious Diseases.
Enrich Therapeutics's latest named round is a Grant, in Aug 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.